Page last updated: 2024-09-03

imatinib mesylate and Diffuse Mixed Small and Large Cell Lymphoma

imatinib mesylate has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (60.00)	29.6817
2010's	3 (30.00)	24.3611
2020's	1 (10.00)	2.80

Authors

Authors	Studies
Amor, IB; Elloumi, M; Kahla, AB; Kallel, F; Kassar, O; Koubaa, A	1
Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A	1
Baerlocher, GM; Brümmendorf, TH; Fabarius, A; Fauser, AA; Flasshove, M; Hanfstein, B; Hasford, J; Hehlmann, R; Heim, D; Hess, U; Hochhaus, A; Hofmann, WK; Hossfeld, DK; Kolb, HJ; Kraus, MP; Krause, SW; Lauseker, M; Mahlberg, R; Miranda, MB; Müller, MC; Neben, K; Nerl, C; Pfirrmann, M; Plöger, C; Proetel, U; Prümmer, O; Rendenbach, B; Saußele, S; Verbeek, W	1
Adil, SN; Kumar, S; Masood, N	1
Blay, JY; Coscas, Y; Khayat, D; Pivot, X; Soria, JC; Spano, JP	1
Houshmand, P; Zlotnik, A	1
Herbers, AH; Keuning, JJ	1
Fujita, H; Kurata, M; Maeda, A; Matsui, T; Matsushita, A; Nagai, K; Sada, A; Takahashi, T; Tanaka, Y; Togami, K; Watanabe, N	1
Alimena, G; Breccia, M; Cannella, L; Finolezzi, E; Frustaci, A; Levi, A; Martelli, M; Russo, E; Stefanizzi, C	1
Avalos, JC; Foncuberta, MC; Tartas, NE	1

Reviews

4 review(s) available for imatinib mesylate and Diffuse Mixed Small and Large Cell Lymphoma

Article	Year
Old disease, new targets. Part-II, haematological malignancies. JPMA. The Journal of the Pakistan Medical Association, 2009, Volume: 59, Issue:8 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Benzamides; Drug Costs; Graft vs Host Disease; Hematologic Neoplasms; Humans; Imatinib Mesylate; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Rituximab; Time Factors	2009
Added value of molecular targeted agents in oncology. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:8 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Benzamides; Biomarkers, Pharmacological; Breast Neoplasms; Female; Humans; Imatinib Mesylate; Indoles; Lymphoma, Non-Hodgkin; Molecular Targeted Therapy; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Receptor, ErbB-2; Rituximab; Sunitinib; Trastuzumab	2011
Targeting tumor cells. Current opinion in cell biology, 2003, Volume: 15, Issue:5 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Benzamides; Chemokines; Drug Therapy; Gene Expression Profiling; Genes, abl; Genes, erbB-2; Humans; Imatinib Mesylate; Integrins; Leukemia, Myelomonocytic, Chronic; Lymphoma, Non-Hodgkin; Metalloproteases; Neoplasm Metastasis; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Rituximab; Stomach Neoplasms; Trastuzumab	2003
[Treatment of hematologic neoplasms during pregnancy]. Medicina, 2007, Volume: 67, Issue:6 Pt 2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Benzamides; Enzyme Inhibitors; Female; Hematologic Neoplasms; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Lymphoma, Non-Hodgkin; Piperazines; Pregnancy; Pregnancy Complications, Neoplastic; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Radiotherapy; Rituximab	2007

Trials

1 trial(s) available for imatinib mesylate and Diffuse Mixed Small and Large Cell Lymphoma

Article	Year
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV. Leukemia, 2016, Volume: 30, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Imatinib Mesylate; Incidence; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Protein Kinase Inhibitors; Sex Factors	2016

Article

Year

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.

Leukemia, 2016, Volume: 30, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Imatinib Mesylate; Incidence; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Protein Kinase Inhibitors; Sex Factors

2016

Other Studies

5 other study(ies) available for imatinib mesylate and Diffuse Mixed Small and Large Cell Lymphoma

Article	Year
Non-Hodgkin's lymphoma developed during imatinib mesylate treatment of chronic myeloid leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:4 Topics: Antineoplastic Agents; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Protein Kinase Inhibitors; Rituximab; Treatment Outcome	2023
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma. Journal of the National Cancer Institute, 2013, Aug-07, Volume: 105, Issue:15 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Dasatinib; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Staging; Piperazines; Platelet Transfusion; Prednisone; Primary Prevention; Procarbazine; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Survival Analysis; Thiazoles; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine; Vindesine	2013
Staging for CLL-type non-Hodgkin's lymphoma reveals a gastrointestinal stromal tumour. The Netherlands journal of medicine, 2005, Volume: 63, Issue:2 Topics: Aged; Benzamides; Biopsy, Needle; Diagnosis, Differential; Follow-Up Studies; Gastrointestinal Stromal Tumors; Gastroscopy; Humans; Imatinib Mesylate; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Piperazines; Pyrimidines; Risk Assessment; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2005
Chronic eosinophilic leukemia with the FIP1L1-PDGFRalpha fusion gene in a patient with a history of combination chemotherapy. International journal of hematology, 2006, Volume: 83, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chronic Disease; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Lymphoma, Non-Hodgkin; Male; Molecular Sequence Data; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Sequence Analysis, DNA	2006
Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma. Leukemia research, 2008, Volume: 32, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Breast Neoplasms; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasms, Second Primary; Piperazines; Pyrimidines; Rituximab	2008